UPDATE 1-US FDA reviewing Abbott diet drug risks
Reuters
WASHINGTON, Nov 20 (Reuters) - US regulators are reviewing preliminary data suggesting patients taking Abbott Laboratories Inc's (ABT.

and more »

Original post click here

Leave a Reply